Anhui Fengyuan Pharmaceutical Company Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 4,278

Employees

  • Stock Symbol
  • 000153

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.80
  • (As of Thursday Closing)

Anhui Fengyuan Pharmaceutical Company General Information

Description

Anhui Fengyuan Pharmaceutical Co Ltd operates in pharmaceutical research and development, production, and sales. The business of the company includes preparations, API, health care, and commercial logistics. The company is engaged in development of bio innovative drugs and in set up of drug distribution branches.

Contact Information

Website
www.bbcayy.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Number 16 Dalian Road
  • Baohe Industrial Zone
  • Hefei, Anhui 230051
  • China
+86 0551
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
SHE
Corporate Office
  • Number 16 Dalian Road
  • Baohe Industrial Zone
  • Hefei, Anhui 230051
  • China
+86 0551

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anhui Fengyuan Pharmaceutical Company Stock Performance

As of 12-Nov-2026, Anhui Fengyuan Pharmaceutical Company’s stock price is $0.80. Its current market cap is $372M with 465M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.80 $0.81 $0.73 - $1.09 $372M 465M 14.9M $0.03

Anhui Fengyuan Pharmaceutical Company Financials Summary

As of 30-Sep-2026, Anhui Fengyuan Pharmaceutical Company has a trailing 12-month revenue of $458M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 580,616 521,465 481,083 514,913
Revenue 457,975 536,510 597,121 604,312
EBITDA 19,356 42,507 50,830 51,788
Net Income 12,312 13,824 22,415 22,514
Total Assets 741,617 723,145 643,683 619,490
Total Debt 202,566 155,426 134,885 97,024
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Anhui Fengyuan Pharmaceutical Company Patents

Anhui Fengyuan Pharmaceutical Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024045344-A1 Preparation method for cyanide antidote injection Inactive 30-Aug-2022

Anhui Fengyuan Pharmaceutical Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anhui Fengyuan Pharmaceutical Company Investments & Acquisitions (3)

Anhui Fengyuan Pharmaceutical Company’s most recent deal was a Merger/Acquisition with Langli Bio for . The deal was made on 17-Dec-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Langli Bio 17-Dec-2020 Merger/Acquisition Drug Discovery
Chengxin Pharmaceutical 13-Jul-2018 Corporate Specialty Chemicals
Chengdu Push Pharmaceutical 14-Apr-2017 Merger/Acquisition Other Containers and Packaging
To view Anhui Fengyuan Pharmaceutical Company’s complete investments and acquisitions history, request access »

Anhui Fengyuan Pharmaceutical Company ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Anhui Fengyuan Pharmaceutical Company’s complete esg history, request access »

Anhui Fengyuan Pharmaceutical Company Exits (1)

Anhui Fengyuan Pharmaceutical Company’s most recent exit was on 13-Jul-2018 from Chengxin Pharmaceutical. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Chengxin Pharmaceutical 13-Jul-2018 Completed
To view Anhui Fengyuan Pharmaceutical Company’s complete exits history, request access »

Anhui Fengyuan Pharmaceutical Company Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Langli Bio Bangbu, China 2019

Anhui Fengyuan Pharmaceutical Company FAQs

  • When was Anhui Fengyuan Pharmaceutical Company founded?

    Anhui Fengyuan Pharmaceutical Company was founded in 1997.

  • Where is Anhui Fengyuan Pharmaceutical Company headquartered?

    Anhui Fengyuan Pharmaceutical Company is headquartered in Hefei, China.

  • What is the size of Anhui Fengyuan Pharmaceutical Company?

    Anhui Fengyuan Pharmaceutical Company has 4,278 total employees.

  • What industry is Anhui Fengyuan Pharmaceutical Company in?

    Anhui Fengyuan Pharmaceutical Company’s primary industry is Pharmaceuticals.

  • Is Anhui Fengyuan Pharmaceutical Company a private or public company?

    Anhui Fengyuan Pharmaceutical Company is a Public company.

  • What is Anhui Fengyuan Pharmaceutical Company’s stock symbol?

    The ticker symbol for Anhui Fengyuan Pharmaceutical Company is 000153.

  • What is the current stock price of Anhui Fengyuan Pharmaceutical Company?

    As of 12-Nov-2026 the stock price of Anhui Fengyuan Pharmaceutical Company is $0.80.

  • What is the current market cap of Anhui Fengyuan Pharmaceutical Company?

    The current market capitalization of Anhui Fengyuan Pharmaceutical Company is $372M.

  • What is Anhui Fengyuan Pharmaceutical Company’s current revenue?

    The trailing twelve month revenue for Anhui Fengyuan Pharmaceutical Company is $458M.

  • What is Anhui Fengyuan Pharmaceutical Company’s annual earnings per share (EPS)?

    Anhui Fengyuan Pharmaceutical Company’s EPS for 12 months was $0.03.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process